09 July 2020
Agreement to file a friendly takeover bid initiated by ONCODNA on INTEGRAGEN to acquire all outstanding shares at a price of 2.20€ per share. This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of (…) »
12 May 2020
Our latest release: MERCURY™ v3.0
We are excited to provide you with important information regarding the release of a new version (v3.0) of MERCURY™. This updated version of MERCURY has a number of changes and improvements designed to enhance data analysis capabilities and the user experience.
13 April 2020
IntegraGen announces the company’s MERCURY™ cloud-based analytical software tool has achieved Conformité Européenne (CE) marking. This registration enhances the ability for IntegraGen sell MERCURY throughout the European Union (EU). MERCURY is utilized by researchers and clinicians to assist with the analysis of sequencing data derived from small (…) »
31 March 2020
IntegraGen is following the French Government’s recommendations and precautionary measures for COVID-19. As an essential supplier of genomic research services, we are committed to meeting the needs of our customers while also making every effort to protect the health and well-being of our employees and their families.
We have undertaken (…) »
17 March 2020
Dear IntegraGen partner and customer,
We value your well-being and understand that the entire community is impacted by the novel coronavirus (COVID-19) outbreak. This is why we are committed to providing consistent and timely support so your important work is not interrupted.
IntegraGen is closely monitoring guidance from health authorities (…) »
20 September 2019
IntegraGen will be attending the 4th International Cancer Symposium sponsored by the Cancer Research Center of Lyon (CRCL).
The aim of the CRCL International Cancer Symposium is to address fundamental issues of cancer biology from the molecular and biochemical determinants of cancer initiation and dissemination, to the impact (…) »
13 March 2019
IntegraGen Genomics is pleased to present:
From high throughput genomic data generation to high level interpretation, an industrial experience of NGS services.
Simplify your RNA-SEQ study from data production to gene expression analysis Get access to the most experienced EXOME sequencing company DNA methylation: discover (…) »
27 December 2018
32nd Annual Genetics Seminar
31 January and 1 February 2019
Faculty of Medicine of Lille, Research Center Lille, France
⇒ View Program
12 November 2018
IntegraGen has announced it is collaborating with Google Cloud for the implementation of IntegraGen’s advanced genomic analysis tools, SIRIUS™ and MERCURY™ into the Google Cloud Platform. This partnership will enable widespread online availability, rapid data transfer and enhanced data security to clinicians and researchers utilizing these analytical tools. (…) »